Thierry Colin, Gaelle Margue, Marine Gross-Goupil, Pierre Bigot, Philippe Barthélémy, Laurence Albiges, Loïc Ferrer, Jean-Christophe Bernhard. "Individualized recurrence risk prediction as a challenge to conventional eligibility criteria in phase III adjuvant immunotherapy trials for renal cell carcinoma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e16501